Glaucoma secondary to iridocorneal endothelial (ICE) syndrome is refractory to medical treatment, and its management is always challenging. Figure 1a shows the clinical photo of a 42-year male patient with ICE syndrome in the left eye (LE) post failed trabeculectomy, who underwent Ahmed glaucoma valve with tube in sulcus placement for control of intra-ocular pressure (IOP). Figure 1b shows the clinical photo taken at 4-month post-operative follow-up, where the retracted tube (white circle) is seen sub-conjunctivally with an elevated IOP of about 32mmHg. He was treated with fixed combination therapy of dorzolamide hydrochloride 2% and timolol maleate 0.5% twice a day in LE. The possible reasons for tube retraction include inadvertently cut tube, kinked tube, or posterior migration of the implant due to faulty suturing of the episcleral plate to the sclera.[1,2]Figure 1: (a) Clinical photo of the LE showing multiple areas of iridocorneal adhesions, with surgical iridectomy at 12'0 clock, failed bleb, and superotemporal Ahmed glaucoma valve implant. (b) Clinical photo taken at 4-month post-operative follow-up, where the retracted tube (white circle) of AGV is seen sub-conjunctivallyDeclaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient (s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and that due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Vijayalakshmi A Senthilkumar (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: